These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31720448)

  • 21. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro.
    Samara P; Ioannou K; Neagu M; Arnogiannaki N; Ardavanis A; Voelter W; Tsitsilonis O
    Int Immunopharmacol; 2013 Jan; 15(1):50-7. PubMed ID: 23201434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.
    Teixeira A; Yen B; Gusella GL; Thomas AG; Mullen MP; Aberg J; Chen X; Hoshida Y; van Bakel H; Schadt E; Basler CF; García-Sastre A; Mosoian A
    J Infect Dis; 2015 May; 211(9):1467-75. PubMed ID: 25404520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prothymosin alpha-deficiency enhances anxiety-like behaviors and impairs learning/memory functions and neurogenesis.
    Ueda H; Sasaki K; Halder SK; Deguchi Y; Takao K; Miyakawa T; Tajima A
    J Neurochem; 2017 Apr; 141(1):124-136. PubMed ID: 28122138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage.
    Matsunaga H; Ueda H
    Cell Death Differ; 2010 Nov; 17(11):1760-72. PubMed ID: 20467443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prothyomosin alpha interaction with KEAP1 doesn't lead to prothymosin alpha ubiquination and degradation].
    Mel'nikov SV; Evstaf'eva AG; Vartapetian AB
    Mol Biol (Mosk); 2007; 41(5):868-75. PubMed ID: 18240569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking.
    Kuo YH; Shiau AL; Tung CL; Su YC; Li CF; Su BH; Tsao CJ; Wu CL; Feng YH; Wu P
    Oncol Lett; 2019 Jun; 17(6):5740-5746. PubMed ID: 31105795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner.
    Skopeliti M; Iconomidou VA; Derhovanessian E; Pawelec G; Voelter W; Kalbacher H; Hamodrakas SJ; Tsitsilonis OE
    Mol Immunol; 2009 Feb; 46(5):784-92. PubMed ID: 18976813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of prothymosin α leads to apoptosis and developmental defects in zebrafish embryos.
    Emmanouilidou A; Karetsou Z; Tzima E; Kobayashi T; Papamarcaki T
    Biochem Cell Biol; 2013 Oct; 91(5):325-32. PubMed ID: 24032683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain.
    Halder SK; Ueda H
    Cell Mol Neurobiol; 2012 Jan; 32(1):59-66. PubMed ID: 21750924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of prothymosin alpha is related to pituitary adenoma recurrence but not to adenoma invasiveness and proliferation.
    Pawlikowski M; Radek M; Kunert-Radek J; Jaranowska M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2014; 65(5):382-6. PubMed ID: 25301489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prothymosinα, as a neuroprotective DAMPs/Alarmins molecule].
    Ueda H; Maeda S
    Nihon Yakurigaku Zasshi; 2018; 151(1):15-19. PubMed ID: 29321391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.
    Mosoian A; Teixeira A; High AA; Christian RE; Hunt DF; Shabanowitz J; Liu X; Klotman M
    J Virol; 2006 Sep; 80(18):9200-6. PubMed ID: 16940531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of zinc binding on the structure and dynamics of the intrinsically disordered protein prothymosin alpha: evidence for metalation as an entropic switch.
    Yi S; Boys BL; Brickenden A; Konermann L; Choy WY
    Biochemistry; 2007 Nov; 46(45):13120-30. PubMed ID: 17929838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells.
    Rodríguez P; Viñuela JE; Alvarez-Fernández L; Buceta M; Vidal A; Domínguez F; Gómez-Márquez J
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):753-61. PubMed ID: 9560301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuron-specific non-classical release of prothymosin alpha: a novel neuroprotective damage-associated molecular patterns.
    Halder SK; Matsunaga H; Ueda H
    J Neurochem; 2012 Oct; 123(2):262-75. PubMed ID: 22853710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular and extracellular cytokine-like functions of prothymosin α: implications for the development of immunotherapies.
    Mosoian A
    Future Med Chem; 2011 Jul; 3(9):1199-208. PubMed ID: 21806381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha.
    Lal A; Kawai T; Yang X; Mazan-Mamczarz K; Gorospe M
    EMBO J; 2005 May; 24(10):1852-62. PubMed ID: 15861128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothymosin α plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms.
    Ueda H; Matsunaga H; Halder SK
    Ann N Y Acad Sci; 2012 Oct; 1269():34-43. PubMed ID: 23045968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new protocol for high-yield purification of recombinant human prothymosin alpha expressed in Escherichia coli for NMR studies.
    Yi S; Brickenden A; Choy WY
    Protein Expr Purif; 2008 Jan; 57(1):1-8. PubMed ID: 17949994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.
    Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A
    Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.